Royalty Pharma annual revenue
2018
2019
2020
2021
2022
2023
2024
2025
Royalty Pharma Revenue Growth & History (RPRX)
Royalty Pharma reported $2.38B in revenue for fiscal 2025, an increase of 5.06% from the previous fiscal year.
View full Royalty Pharma company overviewRoyalty Pharma annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.38B | $114.6M | +5.06% |
| 2024 | 2024-12-31 | $2.26B | −$91.0M | −3.86% |
| 2023 | 2023-12-31 | $2.35B | $117.3M | +5.24% |
| 2022 | 2022-12-31 | $2.24B | −$52.2M | −2.28% |
| 2021 | 2021-12-31 | $2.29B | $167.1M | +7.87% |
| 2020 | 2020-12-31 | $2.12B | $308.1M | +16.98% |
| 2019 | 2019-12-31 | $1.81B | $19.4M | +1.08% |
| 2018 | 2018-12-31 | $1.79B | — | — |
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Primary source
SEC company filings
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review Royalty Pharma filings at SEC.gov ↗